Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schlapbach

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Allergy|October 7, 2014
Update on skin allergyC Schlapbach, D Simon
Seminars in Immunopathology|October 2, 2015
The continuing evolution of targeted therapy for inflammatory skin diseaseC Schlapbach, A A Navarini
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2020
Erythema gyratum repens-like eruption after anti-IL-17 therapy of pityriasis rubra pilarisA D Gloor, M van Rhyn, C Schlapbach
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2017
Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativaR Thomi, M Kakeda, N Yawalkar, et al.
Journal of Dermatological Science|February 9, 2010
Characterization of dendritic cells and macrophages in irritant contact dermatitisH Tang, C Schlapbach, A S Hassan, et al.
The British Journal of Dermatology|November 10, 2020
A relapsing localized variant of neutrophilic dermatosis triggered by tissue injuryA D Gloor, L Feldmeyer, A Rammlmair, et al.
The British Journal of Dermatology|March 17, 2017
Interleukin-32 is highly expressed in lesions of hidradenitis suppurativaR Thomi, D Yerly, N Yawalkar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2016
Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planusB Weber, C Schlapbach, M Stuck, et al.
The British Journal of Dermatology|October 15, 2013
High expression of FOXP3 in primary melanoma is associated with tumour progressionA L Gerber, A Münst, C Schlapbach, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2020
Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndromeO Steck, N L Bertschi, F Luther, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Allergy|October 7, 2014
Update on skin allergyC Schlapbach, D Simon
Seminars in Immunopathology|October 2, 2015
The continuing evolution of targeted therapy for inflammatory skin diseaseC Schlapbach, A A Navarini
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2020
Erythema gyratum repens-like eruption after anti-IL-17 therapy of pityriasis rubra pilarisA D Gloor, M van Rhyn, C Schlapbach
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2017
Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativaR Thomi, M Kakeda, N Yawalkar, et al.
Journal of Dermatological Science|February 9, 2010
Characterization of dendritic cells and macrophages in irritant contact dermatitisH Tang, C Schlapbach, A S Hassan, et al.
The British Journal of Dermatology|November 10, 2020
A relapsing localized variant of neutrophilic dermatosis triggered by tissue injuryA D Gloor, L Feldmeyer, A Rammlmair, et al.
The British Journal of Dermatology|March 17, 2017
Interleukin-32 is highly expressed in lesions of hidradenitis suppurativaR Thomi, D Yerly, N Yawalkar, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2016
Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planusB Weber, C Schlapbach, M Stuck, et al.
The British Journal of Dermatology|October 15, 2013
High expression of FOXP3 in primary melanoma is associated with tumour progressionA L Gerber, A Münst, C Schlapbach, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2020
Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndromeO Steck, N L Bertschi, F Luther, et al.
Pageof 2